Sunday, 25 February 2018
Latest news
Main » Johnson & Johnson wins appeal in $72 million talc cancer risk verdict

Johnson & Johnson wins appeal in $72 million talc cancer risk verdict

18 October 2017

While J&J says it is confident its appeals will be successful, Jim Onder-who represents a number of the plaintiffs in the lawsuits-asserts that Missouri is a proper locations because J&J packages and labels some products in the state.

The verdict was overturned because of a recent Supreme Court ruling on where injury lawsuits can be filed. Consequently, in the Johnson & Johnson lawsuit, only 2 out of the 65 plaintiffs resided in Missouri.

Three other juries have ruled against Johnson & Johnson in similar lawsuits in Missouri. A spokeswoman said the company has consistently argued that Missouri had no jurisdiction in cases involving non-residents and the company expects the existing judgments that are going through the appeals process to be reversed. The Bristol-Myers Squibb case said non-California residents could not file claims there against the New York-based maker of the blood thinner Plavix, ruling that establishing a lawsuit's jurisdiction requires a stronger connection between the forum state and a plaintiff's claims.

Tragically Hip's Gord Downie dead at 53
Gord Downie was diagnosed with a terminal form of cancer known as glioblastoma after suffering a seizure in December 2015. Indigenous leaders are praising Gord Downie's contribution to reconciliation as they mourn his death.

A Birmingham family sued Johnson & Johnson over a family member's ovarian cancer, and initially was awarded millions of dollars.

Alabama resident Jacqueline Fox died in 2015 at the age of 62. The $72 million awarded to Fox by jurors included $10 million in compensatory damages and $62 million in punitive damages.

J&J said it is pleased with the ruling. It involves the Missourian, Michael Blaes of Webster Groves, whose wife died of ovarian cancer.

BHP's copper production up sharply, iron ore down
The Company sells its products through direct supply agreements with its customers and on global commodity exchanges. Many technical traders will be taking a look at different indicators to help figure out where shares may be heading.

This was the first award in several cases that claim Johnson & Johnson's talcum powder contributed to their diagnoses. Johnson & Johnson claimed the studies were not reliable.

The Supreme Court said state courts could not hear claims by non-residents who were not injured in that particular state and where the defendant company was not based in that state.

Johnson & Johnson appealed, and the verdict was thrown out on Tuesday.

How Have Colgate-Palmolive Company (CL) Earnings Estimates Changed?
Shares for $2.44M were sold by Dolan Victoria L on Monday, May 15. 14,000 shares were sold by Marsili Daniel B, worth $1.06M. Its up 0.08, from 0.82 in 2017Q1. 617.46 million shares or 0.79% less from 622.36 million shares in 2017Q1 were reported.

The cases of Fox and other plaintiffs from outside the state were joined with those of plaintiffs from Missouri, though each case resulting in a verdict has been tried individually.

Johnson & Johnson wins appeal in $72 million talc cancer risk verdict